Pharmacoinformatics approach for mPGES-1 in anti-inflammation by 3D-QSAR pharmacophore mapping

被引:39
作者
Chen, Calvin Yu-Chian [1 ]
机构
[1] China Med Univ, Coll Pharm, Dept Biol Sci & Technol, Lab Pharmacoinformat, Taichung 40402, Taiwan
关键词
Inflammation; mPGES-1; Azaphenanthrenone derivatives; HypoGen technique; Pharmacophore; PROSTAGLANDIN-E SYNTHASE-1; E-2; SYNTHASE; DPPC-LIPOSOMES; INHIBITORS; SIMULATION; DISCOVERY; ARTHRITIS; CELECOXIB; RECEPTOR; BIOLOGY;
D O I
10.1016/j.jtice.2008.07.010
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Microsomal prostablandin E synthase-1 (mPGES-1) has been recently investigated to be a novel, hot, and promising target for inflammation-related diseases. The quantitative structure-activity relationship (QSAR) study was used to explore the critical pharmacophore features of mPGES-1 by using a set of 35 azaphenanthrenone derivatives. Twenty-four selected pharmacophore models derived from 240 hypotheses were employed to identify the critical features. The best two pharmacophore hypotheses, generated by HypoGen Technique, exhibited the residuals of approximately 150 and the high correlation coefficient of 0.92. The selected four hypotheses all showed a confidence level of 95% in the Fischer's randomization test. The final four pharmacophore model showed that the four dominant features (hydrogen bond donor and three hydrophobic features, occasionally replaced by ring aromatic feature) had significant impact on activity of mPGES-1 inhibitors, The database virtual screening and drug design can be further implement to searching the novel mPGES-1 inhibitors. (C) 2008 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:155 / 161
页数:7
相关论文
共 54 条
[1]   Human microsomal prostaglandin E synthase-1 (mPGES-1) binding with inhibitors and the quantitative structure-activity correlation [J].
AbdulHameed, Mohamed Diwan M. ;
Hamza, Adel ;
Liu, Junjun ;
Huang, Xiaoqin ;
Zhan, Chang-Guo .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2008, 48 (01) :179-185
[2]  
[Anonymous], 1966, PRINCIPLE EXPT ILLUS
[3]  
Bersuker IB, 2000, IUL BIOTECH, V2, P455
[4]   Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis [J].
Caldwell, B ;
Aldington, S ;
Weatherall, M ;
Shirtcliffe, P ;
Beasley, R .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2006, 99 (03) :132-140
[5]   Inhibiting the vascular smooth muscle cells proliferation by EPC and DPPC liposomes encapsulated magnolol [J].
Chen, Calvin Yu-Chian .
JOURNAL OF THE CHINESE INSTITUTE OF CHEMICAL ENGINEERS, 2008, 39 (05) :407-411
[6]   Insights into the suanzaoren mechanism-From constructing the 3D structure of GABA-A receptor to its binding interaction analysis [J].
Chen, Calvin Yu-Chian .
JOURNAL OF THE CHINESE INSTITUTE OF CHEMICAL ENGINEERS, 2008, 39 (06) :663-671
[7]   Discovery of novel inhibitors for c-Met by virtual screening and pharmacophore analysis [J].
Chen, Calvin Yu-Chian .
JOURNAL OF THE CHINESE INSTITUTE OF CHEMICAL ENGINEERS, 2008, 39 (06) :617-624
[8]   Molecular simulation of HER2/neu degradation by inhibiting HSP90 [J].
Chen, Calvin Yu-Chian ;
Chen, Guan-Wen ;
Chen, Winston Yu-Chen .
JOURNAL OF THE CHINESE CHEMICAL SOCIETY, 2008, 55 (02) :297-302
[9]   A novel perspective on designing the inhibitor of HER2 receptor [J].
Chen, Calvin Yu-Chian .
JOURNAL OF THE CHINESE INSTITUTE OF CHEMICAL ENGINEERS, 2008, 39 (04) :291-299
[10]   What is the effective component in suanzaoren decoction for curing insomnia? Discovery by virtual screening and molecular dynamic simulation [J].
Chen, Calvin Yu-Chian ;
Chen, Yuh-Fung ;
Wu, Chieh-Hsi ;
Tsai, Huei-Yann .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2008, 26 (01) :57-64